The role of oxidized low-density lipoproteins in the pathogenesis of atherosclerosis

Annual Review of Medicine

Volumn 43, Issue , 1992, Pages 219-225

  Parthasarathy, Sampath ^a   Steinberg, Daniel ^a   Witztum, Joseph L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

antioxidants; fatty acid; lipid peroxidation; lipoxygenase; scavenger receptor

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; FATTY ACID; LIPOXYGENASE; LOW DENSITY LIPOPROTEIN; PROBUCOL; SCAVENGER; UBIQUINOL; UNCLASSIFIED DRUG;

AEROBIC METABOLISM; ATHEROSCLEROSIS; HUMAN; HYPERCHOLESTEROLEMIA; LIPID PEROXIDATION; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

EID: 0026631158     PISSN: 00664219     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.me.43.020192.001251     Document Type: Review

References (15)

1. Steinberg, D., Parthasarathy, S., Carew, T. E., Khoo, J. C., Witztum, J. L. 1989. Beyond cholesterol: modifications of low density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320: 915-24
2. Steinberg, D., Witztum, J. L. 1990. Lipoproteins and atherogenesis: current concepts. J. Am. Med. Assoc. 264: 3047-52
3. Goldstein, J. L., Brown, M. S. 1977. The low density lipoprotein pathway and its relation to atherosclerosis. Annu. Rev. Biochem. 46: 897-930
4. Ylä-Herttuala, S., Rosenfeld, M. E., Parthasarathy, S., Sigal, E., Särkioja, T., et al. 1991. Gene expression in macrophage-rich human atherosclerotic lesions: 15-lipoxygenase and acetyl LDL receptor mRNA colocalize with oxidation-specific lipid-protein adducts. J. Clin. Invest. 87: 1146-52
5. Brown, M. S., Basu, S. K., Falck, J. R., Ho, Y. K., Goldstein, J. L. 1980. The scavenger cell pathway for lipoprotein degradation: specificity of the binding site that mediate the uptake of negatively charged LDL by macrophages. J. Supramol. Struct. 13: 67-81
6. Kodama, J., Freeman, M., Rohrer, L., Zabrecky, J., Matsudaira, P., et al.1990. Type 1 macrophage scavenger receptor contains α-helical and collagen-like coiled cells. Nature (London) 343: 531-35
7. Henriksen, T., Mahoney, E. M., Steinberg, D. 1981. Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins. Proc. Natl. Acad. Sci. USA 78: 6499-6503
8. Steinbrecher, U. P., Parthasarathy, S., Leake, D. S., Witztum, J. L., Steinberg, D. 1984. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc. Natl. Acad. Sci. USA 81: 3883-87
9. Morel, D. W., DiCorleto, P. E., Chisolm, G. M. 1984. Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation. Arteriosclerosis 4: 357-64
10. Kugiyama, K., Kerns, S. A., Morrisett, J. D., Roberts, R., Henry, P. D. 1990. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low density lipoprotein. Nature 344: 160-62
11. Gushing, S. D., Berliner, J. A., Valente, A. J., Navab, M., Parhami, F., et al. 1990. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc. Natl. Acad. Sci. USA 87: 5134-38
12. Rajavashisth, T. B., Andalibi, A., Territo, M. C., Berliner, J. A., Navab, et al. 1990. Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low density lipoproteins. Nature 344: 254-57
13. Björkhem, I., Henriksson-Freyschuss, A., Breuer, O., Diczfalusy, U., Berglund, L., Henriksson, P. 1991. The antioxidant butylated hydroxytoluene protects against atherosclerosis. Arteriosclerosis Thrombosis 11: 15-22
14. Ylä-Herttuala, S., Rosenfeld, M. E., Parthasarathy, S., Glass, C. K., Sigal, E., et al. 1990. Colocalization of 15-lipoxygenase mRNA and oxidized low density lipoprotein in macrophage-rich areas of atherosclerotic lesions. Proc. Natl. Acad. Sci. USA 87: 6959-63
15. Gey, K. F., Puska, P. 1989. Plasma vitamins E and A inversely correlated to mortality from ischemic heart disease in cross-cultural epidemiology. Ann. NY Acad. Sci. 570: 268-82